Targeting Chemotherapy-induced Breast Cancer Stemness
Description: PROJECT NARRATIVE Preoperative chemotherapy is increasingly used to treat certain groups of breast cancer patients, but many patients do not respond and/or develop lethal metastatic disease after treatment. Our previous study suggests that chemotherapy causes increased levels of monocyte chemoattractant proteins in the blood that can stimulate cancer stem-like cells to promote malignancy. In the proposed study, we will carry out in-depth dissection of this previously unrecognized effect of conventional chemotherapy, and will test novel strategies to block this effect and maximize the beneficial effects of chemotherapy in breast cancer treatment.
Funder: National Cancer Institute
Funding type: research
Funder scheme: R01
Start date: 2017-08-01
End date: 2023-07-31
Investigator: SHIZHEN EMILY WANG (lead)
Institutions: University of California San Diego, UNIVERSITY OF CALIFORNIA, SAN DIEGO
Topic: Cancer Cells and Metastasis
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Funded outputs count: 20
Funder award ID: R01CA206911
OpenAlex ID: G339727772
